Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.
Q2
Becton, Dickinson falls after Q3 results
Hansen Medical doubles Q2 sales, draws $23M from warrants
Smith & Nephew aims to halve ortho device prices with ‘no-frills’ option
Hologic swings to Q3 black
Strong Q2 can’t buoy HeartWare as shares sink on recall news
Teleflex delivers a beat-and-raise Q2
Abiomed expects FDA nod for Impella sooner than forecast
Haemonetics ticks up on fiscal Q1 numbers
Haemonetics (NYSE:HAE) shares ticked up today after the blood management company beat expectations with its fiscal 1st-quarter results.
NuVasive soars on Q2 sales, earnings beats
Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year
Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.